𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia

✍ Scribed by The French Cooperative Group on CLL; S Johnson; A.G Smith; H Löffler; E Ösby; G Juliusson; B Emmerich; P.J Wyld; W Hiddemann


Book ID
118562127
Publisher
The Lancet
Year
1996
Tongue
English
Weight
1000 KB
Volume
347
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Treatment of chronic lymphocytic leukemi
✍ Emilio Montserrat; Antonio Alcalá; Ricardo Parody; Andreu Domingo; Javier García 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB

Ninety-six patients with advanced chronic lymphocytic leukemia (CLL) (Stage C; anemia and/or thrombocytopenia of nonimmune origin) were randomized to receive either chlorambucil (CLR) (0.4 mg/kg orally, day 6) plus prednime (PDN) (60 mg/m2 orally, days 1-5) every 2 weeks or cyclophosphamide (600 mg/

High dose chlorambucil versus Binet's mo
✍ Branimir Jaksic; Maura Brugiatelli; Ivo Krc; Hajna Losonczi; Jerzy Holowiecki; A 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

vanced and/or progressive disease was defined by high Total Tumor Mass (TTM) score (ú9), and/or short doubling time (DT) (õ12 months), and/or bone marrow for the International Society for Chemo-Immunotherapy, Vienna failure. The response to therapy was defined by reduction of the initial TTM score.